Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fantini

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Inflammatory Bowel Diseases|September 15, 2017
Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down?Massimo C Fantini, Giovanni Monteleone
Current Drug Targets|May 14, 2008
Cytokines: from gut inflammation to colorectal cancerMassimo C Fantini, Francesco Pallone
Cells|April 14, 2019
The Resolution of Intestinal Inflammation: The Peace-Keeper's PerspectiveSara Onali, Agnese Favale, Massimo C Fantini
World Journal of Gastroenterology|May 27, 2009
Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathiesMassimo-C Fantini, Francesco Pallone, Giovanni Monteleone
L'Encephale|August 7, 2007
[Psychological distress in applicants for genetic screening for colorectal cancer]C Fantini, J-L Pedinielli, S Manouvrier
Mutation Research|March 21, 1998
Sister chromatid exchanges and DNA topoisomerase II inhibitors: effect of low concentrations of etoposide (VP-16) in ataxia telangiectasia lymphoblastoid cell linesC Fantini, P Vernole, B Tedeschi, et al.
Nature Protocols|April 5, 2007
High resolution colonoscopy in live miceC Becker, M C Fantini, M F Neurath
Inflammatory Bowel Diseases|August 23, 2007
New players in the cytokine orchestra of inflammatory bowel diseaseMassimo C Fantini, Giovanni Monteleone, Thomas T Macdonald
Mucosal Immunology|December 17, 2008
IL-21 comes of age as a regulator of effector T cells in the gutM C Fantini, G Monteleone, T T MacDonald
Expert Review of Anticancer Therapy|August 23, 2005
Angiogenesis, immune system and growth factors: new targets in colorectal cancer therapyMassimo C Fantini, Christoph Becker, Markus F Neurath
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Inflammatory Bowel Diseases|September 15, 2017
Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down?Massimo C Fantini, Giovanni Monteleone
Current Drug Targets|May 14, 2008
Cytokines: from gut inflammation to colorectal cancerMassimo C Fantini, Francesco Pallone
Cells|April 14, 2019
The Resolution of Intestinal Inflammation: The Peace-Keeper's PerspectiveSara Onali, Agnese Favale, Massimo C Fantini
World Journal of Gastroenterology|May 27, 2009
Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathiesMassimo-C Fantini, Francesco Pallone, Giovanni Monteleone
L'Encephale|August 7, 2007
[Psychological distress in applicants for genetic screening for colorectal cancer]C Fantini, J-L Pedinielli, S Manouvrier
Mutation Research|March 21, 1998
Sister chromatid exchanges and DNA topoisomerase II inhibitors: effect of low concentrations of etoposide (VP-16) in ataxia telangiectasia lymphoblastoid cell linesC Fantini, P Vernole, B Tedeschi, et al.
Nature Protocols|April 5, 2007
High resolution colonoscopy in live miceC Becker, M C Fantini, M F Neurath
Inflammatory Bowel Diseases|August 23, 2007
New players in the cytokine orchestra of inflammatory bowel diseaseMassimo C Fantini, Giovanni Monteleone, Thomas T Macdonald
Mucosal Immunology|December 17, 2008
IL-21 comes of age as a regulator of effector T cells in the gutM C Fantini, G Monteleone, T T MacDonald
Expert Review of Anticancer Therapy|August 23, 2005
Angiogenesis, immune system and growth factors: new targets in colorectal cancer therapyMassimo C Fantini, Christoph Becker, Markus F Neurath
Pageof 9